Skip to main content
. 2020 Oct 19;11(3):305–311. doi: 10.1016/j.jceh.2020.10.005

Table 2.

Outcomes in Patients Treated With Cryoablation.

Characteristic Number (n = 9)
Median follow-up 7 months (range, 3–12 months).
Complete responsea 7 (77.8%)
Partial responsea 2b (22.2%)
Characteristics of tumors with PR
Location Subcapsular [segment III (n = 1) and V (n = 1)]
Size 2.3 cm and 2.1 cm
Adjuvant therapies for residual disease
  • TACE

1 (11.1%)
  • PEI

1 (11.1%)

PR, partial response; TACE, transarterial chemoembolization; PEI, percutaneous ethanol injection; modified RECIST, modified response evaluation criteria in solid tumors.

a

Based on modified RECIST at 1 month.12

b

Both were hepatocellular carcinoma.